glutathione study 2025 september Market Size, Growth Opportunity 2025-2034 Glutathione: Benefits and Supplements
Description
USA 90 , 27542758 (1993)
Dtxsid4042416 39
Oncotarget 7 (1), 610621
Prolactinomas are the most common hormonally active tumors in pregnant women
Data availability Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Birke Bartosch ([email protected])
